Abstract
In vitro activities of omadacycline, a new aminomethylcycline, were determined for Mycoplasma and Ureaplasma spp. and compared with those of azithromycin, clindamycin, moxifloxacin, tetracycline, and doxycycline. All omadacycline MICs were <2 μg/ml. MIC90s were 0.063 μg/ml for Mycoplasma hominis, 0.25 μg/ml for Mycoplasma pneumoniae, and 2 μg/ml for Ureaplasma spp. Omadacycline had the lowest MIC90 among all drugs tested against M. hominis. Omadacycline activity was not affected by macrolide, tetracycline, or fluoroquinolone resistance.
Cite
CITATION STYLE
Waites, K. B., Crabb, D. M., Liu, Y., & Duffy, L. B. (2016). In vitro activities of omadacycline (PTK 0796) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrobial Agents and Chemotherapy, 60(12), 7502–7504. https://doi.org/10.1128/AAC.01734-16
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.